On ECHEMI

Shanghai Tangfang Biotechnology Co., Ltd.

Shanghai,China
Favorite Supplier
 1277 people visit

Company Profile

Shanghai Tangfang Biotechnology Co., Ltd. was founded in 2010. It is a chemical medicine R&D enterprise that engages in development of chemical raw medicine, pharmaceutical intermediates, new products of pharmaceutical preparations, and new technologies; at the same time in drug registration application at home and abroad, patent application of medicine key technologies, and technology transfer; and in offering custom synthesis of new pharmaceutical intermediates and functional compounds.

VIEW MORE VIEW LESS

Product List

Product Name Synonyms CAS No. Grate/Content Operate

((2R,3R,4R)-3-(benzoyloxy)-4-fluoro-4-methyl-5-oxotetrahydrofuran-2-yl)methyl benzoate

D-erythro-Pentonic acid,2-deoxy-2-fluoro-2-methyl-,γ-lactone,3,5-dibenzoate,(2R)-;(2R)-2-Deoxy-2-fluoro-2-methyl-D-erythro-pentonic acid γ-lactone 3,5-dibenzoate;1033394-81-8
874638-80-9 Pharma Grade / 99% Inquiry

(1R,2S)-1-(tert-Butoxycarbonylamino)-2-vinylcyclopropanecarboxylic acid

Cyclopropanecarboxylic acid,1-[[(1,1-dimethylethoxy)carbonyl]amino]-2-ethenyl-,(1R,2S)-;Cyclopropanecarboxylic acid,1-[[(1,1-dimethylethoxy)carbonyl]amino]-2-ethenyl-,(1R-trans)-;(1R,2S)-1-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-ethenylcyclopropanecarboxylic acid;(1R,2S)-1-[(tert-Butoxycarbonyl)amino]-2-vinylcyclopropanecarboxylic acid;(1R,2S)-1-[(tert-Butoxycarbonyl)amino]-2-ethenylcyclopropanecarboxylic acid
159622-10-3 Pharma Grade / 99% Inquiry

(1S,2S)-2-amino-Cyclopentanolhydrochloride

TRANS-(1S 2S)-2-AMINOCYCLOPENTANOL HYDRO;(1s,2s)-trans-2-aminocyclopentanol hydrochloride;(1S,2S)-2-aMinocyclopentanol hydrochloride;(1S,2S)-2-aMinocyclopentan-1-ol hydrochloride;(1S,2S)-trans-2-AMinocyclopentanol HCl;trans-(1S,2S)-2-Aminocyclopentanol HCL;(1S,2S)-trans-2-Aminocyclopentanhydrochloride 98%;(1S,2S)-2-amino-1-cyclopentanol
68327-04-8 Pharma Grade / 99% Inquiry

(1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester

2-Azabicyclo[3.1.0]hexane-2-carboxylic acid,3-(aminocarbonyl)-,1,1-dimethylethyl ester,(1S,3S,5S)-;1,1-Dimethylethyl (1S,3S,5S)-3-(aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylate;tert-Butyl (1S,3S,5S)-3-carbamoyl-2-azabicyclo[3.1.0]hexane-2-carboxylate
361440-67-7 Pharma Grade / 99% Inquiry

(2r,3r)-2-(2,4-difluorophenyl)-1-(1h-1,2,4-triazol-1-yl)-2,3-butanediol

133775-25-4;(2R,3R)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol;(2R,3R)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2,3-butanediol;UNII-1F8K4N408B;1F8K4N408B;132507-94-9;MFCD28902278;(2R,3R)-2-(2,4-DIFLUOROPHENYL)-1-(1,2,4-TRIAZOL-1-YL)BUTANE-2,3-DIOL;Efinaconazole metabolite H2;SCHEMBL2912761
133775-25-4 Pharma Grade / 99% Inquiry

(2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanethioamide

1H-1,2,4-Triazole-1-butanethioamide,β-(2,5-difluorophenyl)-β-hydroxy-α-methyl-,(αR,βR)-;(αR,βR)-β-(2,5-Difluorophenyl)-β-hydroxy-α-methyl-1H-1,2,4-triazole-1-butanethioamide;(2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)thiobutyramide
368421-58-3 Pharma Grade / 99% Inquiry

(2r,3s)-2-(2,4-difluorophenyl)-3-methyl-((1h-1,2,4-triazol-1-yl)methyl)oxirane

127000-90-2;1-(((2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl)methyl)-1H-1,2,4-triazole;UNII-D1JO8189W7;(2R,3S)-2-(2,4-difluorophenyl)-3-methyl-2-[(1H-1,2,4-triazole-1-yl)methyl]oxirane;D1JO8189W7;1-[[(2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl]methyl]-1,2,4-triazole;1-{[(2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl]methyl}-1H-1,2,4-triazole;1H-1,2,4-Triazole, 1-[[(2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiranyl]methyl]-;124627-86-7;132563-77-0
127000-90-2 Pharma Grade / 99% Inquiry

(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valine

(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valine;L-Valine,(2S)-2-cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-Methyl-;TelaprevirInterMediate -3;(2S)-2-Cyclohexyl-N-(pyrazinylcarbonyl)glycyl-3-Methyl-L-valine;(S)-2-[(S)-2-Cyclohexyl-2-[(pyrazinyl-2-carbonyl)aMino]acetylaMino]-3,3-diMethylbutyric Acid;(S)-2-((S)-2-cyclohexyl-2-(pyrazine-2-carboxaMido)acetaMido)-3,3-diMethylbutanoic acid;L-Valine, (2S)-2-cyclohexyl-N-(pyrazinylcarbonyl)glycyl-3-Methyl-;Telaprevir INT1
402958-96-7 Pharma Grade / 99% Inquiry

(2S,3R)-3-(2,5-difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanenitrile

1H-1,2,4-Triazole-1-butanenitrile,β-(2,5-difluorophenyl)-β-hydroxy-α-methyl-,(αS,βR)-;(αS,βR)-β-(2,5-Difluorophenyl)-β-hydroxy-α-methyl-1H-1,2,4-triazole-1-butanenitrile
241479-74-3 Pharma Grade / 99% Inquiry

(3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol

155899-66-4 Pharma Grade / 99% Inquiry

(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan

Furan,3-[4-[(2-chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-,(3S)-;(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydrofuran;(S)-3-(4-(2-Chloro-5-iodobenzyl)phenoxy)tetrahydrofuran;(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]oxolane
915095-94-2 Pharma Grade / 99% Inquiry

(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-furan

Furan, 3-[4-[(5-broMo-2-chlorophenyl)Methyl]phenoxy]tetrahydro-, (3S)-;(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-furan;(S)-3-(4-(5-broMo-2-chlorobenzyl)phenoxy)tetrahydrofuran;EMpagliflozin InterMediate;Empagliflozin Intermediate2;(3S)-3-[4-[(5-bromo-2-chlorophenyl)methyl]phenoxy]oxolane;(3S)-3-(4-(5-bromo-2-chlorobenzyl) methyl]phenoxy]tetrahydro-furan;(35)-3-[4-[(5-Bromo-2-chlorophenyl)methyllphenoxyltetrahydro-furan
915095-89-5 Pharma Grade / 99% Inquiry

(R)-(-)-3-Hydroxytetrahydrofuran

3-Furanol,tetrahydro-,(3R)-;3-Furanol,tetrahydro-,(R)-;(3R)-Tetrahydro-3-furanol;(R)-Tetrahydro-3-furanol;(-)-3-Hydroxytetrahydrofuran;(R)-(-)-3-Hydroxytetrahydrofuran;(R)-3-Hydroxytetrahydrofuran;3(R)-Hydroxytetrahydrofuran;(R)-Tetrahydrofuran-3-ol;(3R)-3-Hydroxytetrahydrofuran;(R)-(-)-Tetrahydrofuran-3-ol;(R)-(-)-Tetrahydrofuran-3-ol;(3R)-Tetrahydrofuran-3-ol;(3R)-Oxolan-3-ol;(3R)-Oxolan-3-ol;(R)-3-Hydroxytetrahydrofuran;(r)-(-)-3-Hydroxytetrahydrofuran;3-Furanol tetrahydro-,(3R)-
86087-24-3 Pharma Grade / 99% Inquiry

(S)-(+)-Hydroxytetrahydrofuran

3-Furanol,tetrahydro-,(3S)-;3-Furanol,tetrahydro-,(S)-;(3S)-Tetrahydro-3-furanol;(S)-Tetrahydro-3-furanol;(S)-(+)-3-Hydroxytetrahydrofuran;(+)-3-Hydroxytetrahydrofuran;(S)-3-Hydroxytetrahydrofuran;3S-Hydroxytetrahydrofuran;(S)-(+)-Tetrahydrofuran-3-ol;(3S)-Tetrahydrofuran-3-ol;(3S)-Oxolan-3-ol;(3S)-Oxolan-3-ol;3-Furanol tetrahydro-,(3S)-
86087-23-2 Pharma Grade / 99% Inquiry

(S)-2-((tert-butoxycarbonyl)amino)-3-(4-carbamoyl-2,6-dimethylphenyl)propanoic acid

(2S)-3-(4-carbamoyl-2,6-dimethylphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid;L-Phenylalanine, 4-(aminocarbonyl)-N-[(1,1-dimethylethoxy)carbonyl]-2,6-dimethyl-;(2S)-2{[(tert-butoxy)carbonyl]amino}-3-(4-carbamoyl-2,6-dimethylphenyl)propanoic acid;(S)-2-(N-BOC-amino)-3-(4-formamido-2,6-dimethylphenyl)propanoic acid;(S)-2-(tert-butoxycarbonylaMino)-3-(4-carbaMoyl-2,6-diMethylphenyl)propanoic aci;4-(Aminocarbonyl)-N-[(1,1-dimethylethoxy)carbonyl]-2,6-dimethyl-L-phenylalanine###NA;4-(Aminocarbonyl)-N-[(1,1-dimethylethoxy)carbonyl]-2,6-dimethyl-L-phenylalanine;(s)-2-(tert-butoxycarbonylaMino)-3-(4-carbaMoyl-2,6-diMethylphenyl)propanoic acid
623950-02-7 Pharma Grade / 99% Inquiry

(S)-6-(3-chloro-2-fluorobenzyl)-7-fluoro-1-(1-hydroxy-3-methylbutan-2-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

6-(3-Chloro-2-fluorobenzyl)-7-fluoro-1-[(S)-1-hydroxyMethyl-2-Methylpropyl]-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid;6-[(3-Chloro-2-fluorophenyl)Methyl]-7-fluoro-1,4-dihydro-1-[(1S)-1-(hydroxyMethyl)-2-Methylpropyl];7-DesMethoxy-7-fluoro Elvitegravir;3-Quinolinecarboxylic acid, 6-[(3-chloro-2-fluorophenyl)Methyl]-7-fluoro-1,4-dihydro-1-[(1S)-1-(hydro xyMethyl)-2-Methylpropyl]-4-oxo-;(S)-6-(3-chloro-2-fluorobenzyl)-7-fluoro-1-(1-hydroxy-3-methylbutan-2-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
869893-92-5 Pharma Grade / 99% Inquiry

(S)-N-Boc-3-hydroxyadamantylglycine

Tricyclo[3.3.1.13,7]decane-1-acetic acid,α-[[(1,1-dimethylethoxy)carbonyl]amino]-3-hydroxy-,(αS)-;(αS)-α-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-hydroxytricyclo[3.3.1.13,7]decane-1-acetic acid;(αS)-α[[(1,1-Dimethylethoxy)carbonyl]amino]-3-hydroxytricyclo[3.3.1.13,7]decane-1-acetic acid;(2S)-[(tert-Butoxycarbonyl)amino](3-hydroxytricyclo[3.3.1.13,7]decan-1-yl)ethanoic acid;(2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-hydroxyadamantan-1-yl)aceticacid
361442-00-4 Pharma Grade / 99% Inquiry

1,2,3,3,4,4-Hexafluorocyclobutene

Cyclobutene,1,2,3,3,4,4-hexafluoro-;Cyclobutene,hexafluoro-;1,2,3,3,4,4-Hexafluorocyclobutene;Perfluorocyclobutene;Hexafluorocyclobutene;1,2,3,3,4,4-Hexafluoro-1-cyclobutene;Flon C 1316;Fron C 1316
697-11-0 Pharma Grade / 99% Inquiry

1,2,3-Triacetyl-5-deoxy-D-ribose, 62211-93-2 high purity

β-D-Ribofuranose,5-deoxy-,1,2,3-triacetate;β-D-Ribofuranose,5-deoxy-,triacetate;1,2,3-Tri-O-acetyl-5-deoxy-β-D-ribofuranose
62211-93-2 Pharma Grade / 99% Inquiry

1-(2-amino-3-bromo-4-methoxyphenyl)ethanone

Ethanone,1-(2-amino-3-bromo-4-methoxyphenyl)-;1-(2-Amino-3-bromo-4-methoxyphenyl)ethanone;1-(2-Amino-3-bromo-4-methoxyphenyl)ethan-1-one
923289-30-9 Pharma Grade / 99% Inquiry

CONTACT INFORMATION

Send an inquiry

Product Name:
Quantity:
Shipment Term:

United States

  • China
  • Albania
  • Algeria
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Brazil
  • Brunei
  • Bulgaria
  • Burkina-faso
  • Burundi
  • Cameroon
  • Canada
  • Cape Verde
  • Cayman Islands
  • Central African
  • Chad
  • Chile
  • Colombia
  • Comoros
  • Cook Is.
  • Costa Rica
  • Croatia
  • Curacao
  • Cyprus
  • Czech
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Honduras
  • Hongkong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Ivory Coast
  • Jamaica
  • Japan
  • Jordan
  • Kampuchea (Cambodia )
  • Kazakstan
  • Kenya
  • Kiribati
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macao, China
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Island
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Norfolk Island
  • North Macedonia
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Cuinea
  • Paraguay
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Republic of the Congo
  • Reunion Island
  • Romania
  • Russia
  • Rwanda
  • Saint Kitts and Nevis
  • Saint Martin
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Slovakia
  • Slovenia
  • Solomon Is
  • Somali
  • South Africa
  • South Korea
  • South Sudan
  • Spain
  • Sri Lanka
  • St.Lucia
  • Suriname
  • Swaziland
  • Sweden
  • Switzerland
  • Taiwan, China
  • Tajikstan
  • Tanzania
  • Thailand
  • The British Virgin Islands
  • The Dominican Republic
  • The Islamic Republic of Mauritania
  • The Islands of st pierre and miquelon
  • The Turks and Caicos Islands
  • Timor-Leste
  • Togo
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Tuvalu
  • Uganda
  • United Arab Emirates
  • United Kingdom
  • United States
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican
  • Vietnam
  • Wallis et Futuna
  • Western Sahara
  • Yemen
  • Zaire
  • Zambia
  • Zimbabwe
  • Afghanistan
  • Belarus
  • Cuba
  • Iran
  • Iraq
  • Libya
  • North Korea
  • Sudan
  • Syria
  • Ukraine
  • Venezuela
Message:
0/2000
Accept quotations from other qualified suppliers on ECHEMI.com

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.